Perspective Therapeutics (CATX) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Perspective Therapeutics (CATX) over the last 16 years, with Q3 2025 value amounting to -$26.0 million.
- Perspective Therapeutics' Profit After Tax fell 7172.99% to -$26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$105.8 million, marking a year-over-year decrease of 6586.97%. This contributed to the annual value of -$79.3 million for FY2024, which is 7046.31% down from last year.
- According to the latest figures from Q3 2025, Perspective Therapeutics' Profit After Tax is -$26.0 million, which was down 7172.99% from -$21.5 million recorded in Q2 2025.
- Perspective Therapeutics' 5-year Profit After Tax high stood at -$371000.0 for Q1 2023, and its period low was -$40.2 million during Q4 2024.
- In the last 5 years, Perspective Therapeutics' Profit After Tax had a median value of -$10.4 million in 2023 and averaged -$11.2 million.
- As far as peak fluctuations go, Perspective Therapeutics' Profit After Tax skyrocketed by 7245.73% in 2023, and later plummeted by 321105.12% in 2024.
- Quarter analysis of 5 years shows Perspective Therapeutics' Profit After Tax stood at -$1.6 million in 2021, then crashed by 357.29% to -$7.3 million in 2022, then crashed by 236.4% to -$24.7 million in 2023, then plummeted by 62.79% to -$40.2 million in 2024, then surged by 35.35% to -$26.0 million in 2025.
- Its Profit After Tax stands at -$26.0 million for Q3 2025, versus -$21.5 million for Q2 2025 and -$18.2 million for Q1 2025.